SCHEMBL13645704

SCHEMBL13645704

C/C(=N/O)c1ccc(-c2ccc(/C(C)=N/O)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 6/20 0.47
POLB P06746 1/20 0.45
CASP3 P42574 1/20 0.45
GFER P55789 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
MAPT P10636 4/20 0.44
RAB9A P51151 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 1/20 0.42
FURIN P09958 1/20 0.42
LMNA P02545 2/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14298196 0.91 CA9 (0.52) CA9POLBCASP3GFERSENP8
SCHEMBL12360950 0.91 CA9 (0.52) CA9POLBCASP3GFERSENP8
SCHEMBL8306282 0.91 CA9 (0.51) CA9POLBCASP3GFERSENP8
SCHEMBL3368876 0.91 SMN1; SMN2 (0.56) CA9POLBCASP3GFERSENP8
SCHEMBL4316450 0.91 SMN1; SMN2 (0.56) CA9POLBCASP3GFERSENP8
SCHEMBL5609938 0.89 LMNA (0.50) CA9POLBCASP3GFERSENP8
SCHEMBL8308938 0.87 CYP17A1 (0.46) CA9MAPTCYP3A4KDM4ELMNA
SCHEMBL5608949 0.85 SMN1; SMN2 (0.59) CA9CASP3SENP8SENP7SENP6
SCHEMBL8309008 0.83 KIF11 (0.50) CA9RAB9ALMNAALDH1A1
SCHEMBL27364938 0.83 HRH3 (0.54) CA9KDM4EHPGDHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601873-B2 Method of manufacturing 3,3′,4,4′-tetraaminobiphenyl SHOWA DENKO K.K. (JP) 2009-10-13 US disclosed
US-20090149676-A1 METHOD OF MANUFACTURING 3, 3' , 4, 4'-TETRAAMINOBIPHENYL SHOWA DENKO K. K. (JP) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149676-A1 METHOD OF MANUFACTURING 3, 3' , 4, 4'-TETRAAMINOBIPHENYL BRI3BP, TH, TST CA9 3124/4885POLB 2975/4885CASP3 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.